查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1845724

全球整形外科和皮質系統手術市場規模（按手術程序、手術部位、應用、最終用戶、區域範圍和預測）

Global Plastic Surgery And Integumentary System Procedures Market Size By Procedure, By Operating Area, By Application, By End User, By Geographic Scope And Forecast
出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

整形外科和表皮手術的市場規模和預測

2024 年整形外科和附屬器官系統手術市場規模為 302 萬美元，預計到 2031 年將達到 459 萬美元，在 2024-2031 年預測期內的複合年成長率為 5.40%。

市場促進因素包括：美容整形需求成長、政府醫療保健和研發支出增加、癌症患者激增、可支配收入增加以及生活方式的改變。本報告對全球美容整形和皮下組織手術市場進行了全面的評估和分析，涵蓋關鍵細分市場、趨勢、市場促進因素、限制因素、競爭格局以及影響市場的關鍵因素。

定義全球整形外科和皮膚科手術市場

整形外科最基本的定義是用來重組、矯正或修復受損皮膚、組織或其他身體部位的治療。它分為重組手術和美容手術。燒燙傷、擦傷和其他損傷可透過重組手術治療。而美容手術通常用於改善外觀，包括侵入性治療和微創治療。它既可用於醫療目的，也可用於美容目的。皮膚外皮系統由外分泌腺、毛髮、指甲和皮膚組成。醫生和其他專家可能會建議在諸如足癬、皮膚癌和痤瘡等情況下進行表皮系統手術。

在現代，這類手術變得越來越普遍。最初，它們只是為了醫療目的而進行，但生活方式的改變和技術的進步也促使人們出於美容目的而進行手術。許多人為了增強自信，會透過手術來改變嘴唇、鼻子和其他身體特徵。如今，可供選擇的手術種類繁多。

全球整形外科和皮質系統手術市場概覽

市場促進因素包括：對整容手術的需求不斷成長、政府在醫療保健和研發方面的支出不斷增加、癌症患者數量激增、可支配收入不斷增加以及生活方式的改變。政府在醫療保健領域研發方面的支出不斷增加，推動了技術進步。因此，現在有多種整形手術可供選擇。相當一部分人選擇豐唇和隆鼻等美容療程。因此，市場預計將持續成長。

隨著可支配所得的增加，新一代族群更願意支付並接受這些手術。生活方式的改變導致社群媒體的使用和媒體曝光度增加。這些平台正在影響人們的視角和思考方式。這導致了人們對美的看法以及對美的期望改變了。預計這將導致市場規模的擴大。生活方式的改變導致肥胖和癌症的發生率上升。例如，乳房切除手術已成為乳癌治療的關鍵。

此外，肥胖病例的增加和社交媒體影響力的不斷增強，促使許多人接受抽脂和其他消脂治療。保持青春和魅力的願望也日益普遍。因此，許多女性正在接受肉毒桿菌注射和眼部提升等手術。這些因素預計將擴大市場。

手術成本、相關風險以及相關的社會問題預計將阻礙市場擴張。這些手術和程序本身就成本高昂。此外，藥物和其他耗材的需求可能會增加維護和保養成本。許多人，尤其是女性，會接受諸如肉毒桿菌注射、臉頰提升和眼部提升等整容手術。這些手術是不可逆的。如果這些手術失敗，則無法修復損傷。

目錄

第1章 全球整形及內臟外科市場簡介

  • 市場定義
  • 市場區隔
  • 調查時間表
  • 先決條件
  • 限制

第2章：已驗證的市場調查方法

  • 資料探勘
  • 數據三角測量
  • 自下而上的方法
  • 自上而下的方法
  • 調查流程
  • 業界專家的重要見解
  • 資料來源

第3章執行摘要

  • 市場概況
  • 生態測繪
  • 絕對的商機
  • 市場吸引力
  • 全球整形外科和內臟器官系統手術市場的區域分析
  • 全球整形外科和附屬器官手術市場（按手術類型分類）（百萬美元）
  • 全球整形外科及附屬器官手術市場（按手術部位分類）（百萬美元）
  • 全球整形外科和附屬器官手術市場應用（百萬美元）
  • 全球整形外科和附屬器官手術市場（按最終用戶分類）（百萬美元）
  • 未來市場機遇
  • 世界市場結構
  • 產品生命線

第4章 整形外科和內臟器官手術的全球市場展望

  • 全球整形外科和附屬器官手術的演變
  • 驅動程式
    • 促進要素1
    • 促進要素2
  • 阻礙因素
    • 阻礙因素1
    • 阻礙因素2
  • 機會
    • 機會 1
    • 機會 2
  • 波特五力模型
  • 價值鏈分析
  • 定價分析
  • 宏觀經濟分析

5. 全球整形外科和腸道手術市場（依手術類型）

  • 概述
  • 預填充式注射器切片檢查
  • 切除活體組織切片
  • 切口切片檢查
  • 文化與敏感度
  • 皮膚測試

6. 全球整形外科和消化器官系統手術市場（依手術部位分類）

  • 概述
  • 眼皮
  • 皮下組織
  • 胸部
  • 鼻子
  • 皮膚

7. 全球整形消化器官系統外科市場（按應用）

  • 概述
  • 皮膚移植
  • 同種異體移植
  • 自體移植
  • 感染疾病
  • 足癬
  • 皮膚癌
  • 增強

8. 全球整形外科和腸道手術市場（依最終用途）

  • 概述
  • 醫院和診所
  • 研究所
  • 研究所

9. 全球整形外科和腸道手術市場（按地區）

  • 概述
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 其他亞太地區
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲
  • 中東和非洲
    • 阿拉伯聯合大公國
    • 沙烏地阿拉伯
    • 南非
    • 其他中東和非洲地區

第 10 章全球整形外科和皮膚病手術市場的競爭格局

  • 概述
  • 各公司市場排名
  • 主要進展
  • 公司地理分佈
  • 公司產業足跡
  • ACE矩陣

第11章：公司簡介

  • Allergen Inc.
  • CYNOSURE INC.
  • Alma Lasers
  • Lumenis
  • Galderma
  • Merz Pharma
  • Valeant Pharmaceuticals
  • Sanofi
  • Integra Lifesciences
  • Scivision Biotech Inc.

第12章 重大進展

  • 產品發布/開發
  • 併購
  • 業務擴展
  • 夥伴關係和聯盟

第 13 章：經過驗證的市場情報

  • 關於已驗證的市場情報
  • 動態資料視覺化
簡介目錄
Product Code: 157005

Plastic Surgery And Integumentary System Procedures Market Size And Forecast

Plastic Surgery And Integumentary System Procedures Market size was valued at USD 3.02 Million in 2024 and is projected to reach USD 4.59 Million by 2031, growing at a CAGR of 5.40% during the forecast period 2024-2031.

Some of the key market-driving drivers are rising demand for cosmetic surgery, rising government spending on healthcare and R&D, a sharp rise in cancer cases, rising disposable income, and changes in lifestyle. The Global Plastic Surgery And Integumentary System Procedures Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Plastic Surgery And Integumentary System Procedures Market Definition

Plastic surgery, in its most basic definition, is a treatment used to reconstruct, modify, or repair damaged skin, tissues, or any other bodily component. It can be categorized as either a reconstructive or cosmetic operation. Burns, bruising, and other injuries are treated with reconstructive surgery. On the other hand, cosmetic operations, which are typically performed to improve one's appearance, encompass both invasive and less invasive treatments. It is done for both medicinal and cosmetic purposes. The integumentary system is made up of exocrine glands, hair, nails, and skin. In situations of athlete's foot, skin cancer, acne, etc., a doctor or other specialist will recommend integumentary system surgeries.

In the modern day, these operations are more frequent and widespread. Originally performed only for medical reasons, they have become more popular for cosmetic reasons as well due to changing lifestyles and technological improvements. Many people have started having operations to change their lips, noses, and other physical features in order to feel more confident. Today, a wide variety of operations are offered.

Global Plastic Surgery And Integumentary System Procedures Market Overview

Some of the key market-driving drivers are rising demand for cosmetic surgery, rising government spending on healthcare and R&D, a sharp rise in cancer cases, rising disposable income, and changes in lifestyle. Increased government spending on R&D in the healthcare sector has led to technological advancements. As a result, currently, there are several operations accessible. A sizable portion of the population is increasingly choosing cosmetic treatments like lip fillers or nose surgery. The market is anticipated to grow as a result.

A newer sector of the population may now pay and receive these operations due to an increase in disposable income. Social media usage and media exposure have risen as a result of lifestyle changes. These platforms have an impact on how people see and think. This has caused a change in how people view beauty and what they should appear like. The market is anticipated to expand as a result of this. Obesity and cancer rates have increased as a result of lifestyle changes. Mastectomy surgery, for example, becomes crucial in the management of breast cancer.

Additionally, the rise in obesity cases and the growing impact of social media encourage many people to have liposuction and other fat-removal treatments. The desire to maintain one's youth and attractiveness has also become more popular. As a result, a lot of women have procedures like Botox, eye lifts, etc. The market is anticipated to expand as a result of all these factors.

The expense of surgery, accompanying dangers, and related societal issues are anticipated to impede market expansion. These operations and processes cost a lot of money on their own. In addition, the expenses of maintenance and upkeep may increase due to the need for medications and other supplies. Many people, mostly women, get cosmetic procedures including Botox, cheek lifts, and eye lifts. These operations cannot be reversed. There is no way to repair the harm if these procedures are unsuccessful.

Global Plastic Surgery And Integumentary System Procedures Market Segmentation Analysis

The Global Plastic Surgery And Integumentary System Procedures Market is Segmented on the basis of Procedure, Operating Area, Application, End User, And Geography.

Plastic Surgery And Integumentary System Procedures Market, By Procedure

Prefilled Syringe Biopsy

Excisional Biopsy

Incisional Biopsy

Culture and Sensitivity

Skin Tests

Based on Procedure, the Plastic Surgery And Integumentary System Procedures Market is segmented into Prefilled Syringe Biopsy, Excisional Biopsy, Incisional Biopsy, Culture and Sensitivity, and Skin Tests. The use of a prefilled syringe biopsy, sometimes referred to as a vacuum-assisted biopsy or core biopsy, is a minimally invasive technique for obtaining tissue samples from the body for diagnostic reasons. Common applications include examining suspicious lesions or growths in the breast, liver, lung, prostate, or kidney.

A whole aberrant tissue or lesion, along with a border of healthy tissue, is surgically removed during an excisional biopsy in order to be further examined and diagnosed. When there is a possibility of cancer or another serious condition, this kind of biopsy is frequently carried out. Excisional biopsy may be required to make a conclusive diagnosis when there is a strong suspicion of cancer or other malignant diseases. In these situations, an excisional biopsy enables the full removal of the suspect tissue for further inspection.

Plastic Surgery And Integumentary System Procedures Market, By Operating Area

Eyelids

Subcutaneous Tissue

Breast

Nose

Skin

Based on Operating Area, the Plastic Surgery And Integumentary System Procedures Market is segmented into Eyelids, Subcutaneous Tissue, Breast, Nose, and Skin. The area surrounding the eyelids has undergone more and more plastic surgery treatments in recent years. In operations involving the eyelids, the skin, and tissues around the eyes is the primary focus. The integumentary system includes the skin, hair, nails, and associated glands. Sagging or drooping eyelids are a normal result of the natural decrease of muscle tone and skin flexibility that occurs as the population ages. This could make you look old or worn out. By eliminating extra skin and fat deposits, eyelid operations like blepharoplasty can revitalize the eyelids, giving them a more young and rejuvenated appearance.

Furthermore, operations for breast and integumentary plastic surgery have seen a substantial increase in popularity. These operations are intended to improve the breasts' look, shape, and symmetry. Many people choose breast treatments, including breast augmentation or breast lifts, to improve the shape of their whole body and fulfill their cosmetic objectives. Breast augmentation is the process of enhancing the size and form of the breasts by the use of implants. Breast lift operations restore a more youthful and elevated look by addressing sagging or drooping breasts.

Plastic Surgery And Integumentary System Procedures Market, By Application

Skin Grafts

Allograft

Autograft

Infection

Athlete's Foot

Skin Cancer

Augmentation

Based on Application, the Plastic Surgery And Integumentary System Procedures Market is segmented into Skin Grafts, Allograft, Autograft, Infection, Athlete's Foot, Skin Cancer, and Augmentation. Skin grafting is a surgical operation that replaces missing or damaged skin with healthy skin taken from either a donor or another portion of the patient (autograft or allograft). It is frequently used to heal severe wounds, burns, or regions where the skin has been surgically removed. Skin grafts help the damaged region operate better, recover faster, and look better.

A sort of tissue graft called an allograft is utilized in medical treatments, such as skin grafting. It entails the transplantation of tissue from a donor who is a member of the same species but a distinct person. An allograft is the use of skin tissue from a human donor in the context of skin transplantation. Allografts often use dead donors who gave their consent to tissue donation to provide the donor skin. To guarantee the security and compatibility of the donor tissue, certain regulations and screening processes are followed.

Plastic Surgery And Integumentary System Procedures Market, By End User

Hospitals and Clinics

Research Laboratories

Research Institutes

Based on End User, the Plastic Surgery And Integumentary System Procedures Market is segmented into Hospitals and Clinics, Research Laboratories, and Research Institutes. The demand for integumentary system treatments and plastic surgery is increasing in hospitals and clinics for a variety of reasons. Over time, treatments affecting the integumentary system and plastic surgery have gained societal acceptance and lost some of their stigmas. People are increasingly accepting of the concept of using surgical or non-surgical techniques to improve their looks or address certain issues. The demand for such operations has increased as a result of this change in public attitudes.

Furthermore, plastic surgery and integumentary operations are now safer, more efficient, and need less recovery time because of advancements in surgical methods, tools, and technology. Due to their rapid recovery periods and effective outcomes, minimally invasive procedures including laser therapy, injectables, and non-surgical skin rejuvenation methods have grown in popularity.

Plastic Surgery And Integumentary System Procedures Market, By Geography

North America

Europe

Asia Pacific

Rest of the world

Based on Regional Analysis, the Global Plastic Surgery And Integumentary System Procedures Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. Most of the market share is anticipated to come from North America. This can be ascribed to the expanding demand for cosmetic operations, rising government spending on healthcare facilities, shifting consumer lifestyle preferences, and rising R&D spending. Due to similar factors, Europe is anticipated to have the second-largest market share. Due to the area's developing economies, which eventually encourage investment in healthcare and raise disposable income, the Asia Pacific region is predicted to have the biggest growth.

Key Players

The "Global Plastic Surgery And Integumentary System Procedures Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Allergen Inc., CYNOSURE INC., Alma Lasers, Lumenis, Galderma, Merz Pharma, Valeant Pharmaceuticals, Sanofi, Integra Lifesciences, and Scivision Biotech Inc.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis.

Key Developments

  • The newest generation of breast implants, PERLETM, has been introduced by GC Aesthetics, Inc. (GCA), a privately held medical technology company that provides aesthetic solutions for international healthcare markets. An industry-leading gel technology (EmunomicTM Breast Tissue Dynamic Gel) from GCA, a proprietary surface technology (BioQTM), and an improved version of the security features that have supported GCA's long-standing excellent safety record define the PERLETM line of smooth breast implants.
  • The innovative product line gives surgeons and patients access to an innovative range of smooth implants that benefit from GCA's more than 40 years in the business, its long-standing commitment to patient security and innovation, and its exemplary track record of customer care and support.
  • According to Galderma, the FDA has authorized Restylane Defyne for the augmentation and treatment of mild to moderate chin retrusion in mature adults over the age of 21. Online searches for chin augmentation increased by 185% in 2020 alone, contributing to the growing patient demand for a treatment like Restylane Defyne. The first and only chin filler to show outcomes across a wide range of participants, including individuals with various skin types, male subjects, and participants over the age of 52, is Restylane Defyne. Galderma stated that the US FDA had approved RESTYLANE DEFYNE for use in persons over the age of 21 who have mild to moderate chin retrusion.
  • Ace Matrix Analysis
  • The Ace Matrix provided in the report would help to understand how the major key players involved in this industry are performing as we provide a ranking for these companies based on various factors such as service features & innovations, scalability, innovation of services, industry coverage, industry reach, and growth roadmap. Based on these factors, we rank the companies into four categories as Active, Cutting Edge, Emerging, and Innovators.
  • Market Attractiveness
  • The image of market attractiveness provided would further help to get information about the region that is majorly leading in the Global Plastic Surgery And Integumentary System Procedures Market. We cover the major impacting factors that are responsible for driving the industry growth in the given region.
  • Porter's Five Forces
  • The image provided would further help to get information about Porter's five forces framework providing a blueprint for understanding the behavior of competitors and a player's strategic positioning in the respective industry. Porter's five forces model can be used to assess the competitive landscape in the Global Plastic Surgery And Integumentary System Procedures Market, gauge the attractiveness of a certain sector, and assess investment possibilities.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL PLASTIC SURGERY AND INTEGUMENTARY SYSTEM PROCEDURES MARKET

  • 1.1 Market Definition
  • 1.2 Market Segmentation
  • 1.3 Research Timelines
  • 1.4 Assumptions
  • 1.5 Limitations

2 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 2.1 Data Mining
  • 2.2 Data Triangulation
  • 2.3 Bottom-Up Approach
  • 2.4 Top-Down Approach
  • 2.5 Research Flow
  • 2.6 Key Insights from Industry Experts
  • 2.7 Data Sources

3 EXECUTIVE SUMMARY

  • 3.1 Market Overview
  • 3.2 Ecology Mapping
  • 3.3 Absolute Market Opportunity
  • 3.4 Market Attractiveness
  • 3.5 Global Plastic Surgery And Integumentary System Procedures Market Geographical Analysis (CAGR %)
  • 3.6 Global Plastic Surgery And Integumentary System Procedures Market, By Procedure (USD Million)
  • 3.7 Global Plastic Surgery And Integumentary System Procedures Market, By Operating Area (USD Million)
  • 3.8 Global Plastic Surgery And Integumentary System Procedures Market, By Application (USD Million)
  • 3.9 Global Plastic Surgery And Integumentary System Procedures Market, By End User (USD Million)
  • 3.10 Future Market Opportunities
  • 3.11 Global Market Split
  • 3.12 Product Life Line

4 GLOBAL PLASTIC SURGERY AND INTEGUMENTARY SYSTEM PROCEDURES MARKET OUTLOOK

  • 4.1 Global Plastic Surgery And Integumentary System Procedures Evolution
  • 4.2 Drivers
    • 4.2.1 Driver 1
    • 4.2.2 Driver 2
  • 4.3 Restraints
    • 4.3.1 Restraint 1
    • 4.3.2 Restraint 2
  • 4.4 Opportunities
    • 4.4.1 Opportunity 1
    • 4.4.2 Opportunity 2
  • 4.5 Porters Five Force Model
  • 4.6 Value Chain Analysis
  • 4.7 Pricing Analysis
  • 4.8 Macroeconomic Analysis

5 GLOBAL PLASTIC SURGERY AND INTEGUMENTARY SYSTEM PROCEDURES MARKET, BY PROCEDURE

  • 5.1 Overview
  • 5.2 Prefilled Syringe Biopsy
  • 5.3 Excisional Biopsy
  • 5.4 Incisional Biopsy
  • 5.5 Culture and Sensitivity
  • 5.6 Skin Tests

6 GLOBAL PLASTIC SURGERY AND INTEGUMENTARY SYSTEM PROCEDURES MARKET, BY OPERATING AREA

  • 6.1 Overview
  • 6.2 Eyelids
  • 6.3 Subcutaneous Tissue
  • 6.4 Breast
  • 6.5 Nose
  • 6.6 Skin

7 GLOBAL PLASTIC SURGERY AND INTEGUMENTARY SYSTEM PROCEDURES MARKET, BY APPLICATION

  • 7.1 Overview
  • 7.2 Skin Grafts
  • 7.3 Allograft
  • 7.4 Autograft
  • 7.5 Infection
  • 7.6 Athlete's Foot
  • 7.7 Skin Cancer
  • 7.8 Augmentation

8 GLOBAL PLASTIC SURGERY AND INTEGUMENTARY SYSTEM PROCEDURES MARKET, BY END USE

  • 8.1 Overview
  • 8.2 Hospitals and Clinics
  • 8.3 Research Laboratories
  • 8.4 Research Institutes

9 GLOBAL PLASTIC SURGERY AND INTEGUMENTARY SYSTEM PROCEDURES MARKET, BY GEOGRAPHY

  • 9.1 Overview
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 U.K.
    • 9.3.3 France
    • 9.3.4 Italy
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Argentina
    • 9.5.3 Rest of Latin America
  • 9.6 Middle-East and Africa
    • 9.6.1 UAE
    • 9.6.2 Saudi Arabia
    • 9.6.3 South Africa
    • 9.6.4 Rest of Middle-East and Africa

10 GLOBAL PLASTIC SURGERY AND INTEGUMENTARY SYSTEM PROCEDURES MARKET COMPETITIVE LANDSCAPE

  • 10.1 Overview
  • 10.2 Company Market Ranking
  • 10.3 Key Developments
  • 10.4 Company Regional Footprint
  • 10.5 Company Industry Footprint
  • 10.6 ACE Matrix

11 COMPANY PROFILES

  • 11.1 Allergen Inc.
    • 11.1.1 Company Overview
    • 11.1.2 Company Insights
    • 11.1.3 Product Benchmarking
    • 11.1.4 Key Developments
    • 11.1.5 Winning Imperatives
    • 11.1.6 Current Focus & Strategies
    • 11.1.7 Threat from Competition
    • 11.1.8 SWOT Analysis
  • 11.2 CYNOSURE INC.
    • 11.2.1 Company Overview
    • 11.2.2 Company Insights
    • 11.2.3 Product Benchmarking
    • 11.2.4 Key Developments
    • 11.2.5 Winning Imperatives
    • 11.2.6 Current Focus & Strategies
    • 11.2.7 Threat from Competition
    • 11.2.8 SWOT Analysis
  • 11.3 Alma Lasers
    • 11.3.1 Company Overview
    • 11.3.2 Company Insights
    • 11.3.3 Product Benchmarking
    • 11.3.4 Key Developments
    • 11.3.5 Winning Imperatives
    • 11.3.6 Current Focus & Strategies
    • 11.3.7 Threat from Competition
    • 11.3.8 SWOT Analysis
  • 11.4 Lumenis
    • 11.4.1 Company Overview
    • 11.4.2 Company Insights
    • 11.4.3 Product Benchmarking
    • 11.4.4 Key Developments
    • 11.4.5 Winning Imperatives
    • 11.4.6 Current Focus & Strategies
    • 11.4.7 Threat from Competition
    • 11.4.8 SWOT Analysis
  • 11.5 Galderma
    • 11.5.1 Company Overview
    • 11.5.2 Company Insights
    • 11.5.3 Product Benchmarking
    • 11.5.4 Key Developments
    • 11.5.5 Winning Imperatives
    • 11.5.6 Current Focus & Strategies
    • 11.5.7 Threat from Competition
    • 11.5.8 SWOT Analysis
  • 11.6 Merz Pharma
    • 11.6.1 Company Overview
    • 11.6.2 Company Insights
    • 11.6.3 Product Benchmarking
    • 11.6.4 Key Developments
    • 11.6.5 Winning Imperatives
    • 11.6.6 Current Focus & Strategies
    • 11.6.7 Threat from Competition
    • 11.6.8 SWOT Analysis
  • 11.7 Valeant Pharmaceuticals
    • 11.7.1 Company Overview
    • 11.7.2 Company Insights
    • 11.7.3 Product Benchmarking
    • 11.7.4 Key Developments
    • 11.7.5 Winning Imperatives
    • 11.7.6 Current Focus & Strategies
    • 11.7.7 Threat from Competition
    • 11.7.8 SWOT Analysis
  • 11.8 Sanofi
    • 11.8.1 Company Overview
    • 11.8.2 Company Insights
    • 11.8.3 Product Benchmarking
    • 11.8.4 Key Developments
    • 11.8.5 Winning Imperatives
    • 11.8.6 Current Focus & Strategies
    • 11.8.7 Threat from Competition
    • 11.8.8 SWOT Analysis
  • 11.9 Integra Lifesciences
    • 11.9.1 Company Overview
    • 11.9.2 Company Insights
    • 11.9.3 Product Benchmarking
    • 11.9.4 Key Developments
    • 11.9.5 Winning Imperatives
    • 11.9.6 Current Focus & Strategies
    • 11.9.7 Threat from Competition
    • 11.9.8 SWOT Analysis
  • 11.10 Scivision Biotech Inc.
    • 11.10.1 Company Overview
    • 11.10.2 Company Insights
    • 11.10.3 Product Benchmarking
    • 11.10.4 Key Developments
    • 11.10.5 Winning Imperatives
    • 11.10.6 Current Focus & Strategies
    • 11.10.7 Threat from Competition
    • 11.10.8 SWOT Analysis

12 KEY DEVELOPMENTS

  • 12.1 Product Launches/Developments
  • 12.2 Mergers and Acquisitions
  • 12.3 Business Expansions
  • 12.4 Partnerships and Collaborations

13 VERIFIED MARKET INTELLIGENCE

  • 12.1 About Verified Market Intelligence
  • 12.2 Dynamic Data Visualization